Medtronic, Inc. has announced the closing of the acquisition of Cardiocom, a privately held developer and provider of integrated telehealth and patient services for the management of chronic diseases. Medtronic expects the net impact from this $200M cash transaction to be neutral to fiscal year 2014 earnings.
Medtronic says it is a company in transition to being more than just a device company. In a form of vertical integration the company is aiming to expand its medical device product offerings to broader healthcare services and solutions.
And where better to start than cardiovascular telehealth? The first area of focus for Medtronic will be in heart failure, where the addition of the Cardiocom technology and patient services to its product offerings will expand its reach to more patients across the heart failure care continuum.
Already a massive player in the chronic disease areas of cardiovascular, pain, and diabetes, Medtronic is extending its market-leading technology portfolio to include focused, complementary services and solutions that treat patients beyond those who solely rely on or need implanted medical devices.
Cardiocom is specifically focused on a number of important challenging diseases, such as diabetes and cardiovascular disease, including heart failure and hypertension. Cardiocom’s products and services include remote monitoring and patient-centered software to enable efficient care coordination and specialized telehealth nurse support. These integrated solutions are aimed at reporting real-time patient data and proactive patient intervention programs to payers and healthcare providers based on accepted guidelines and evidenced-based protocols, which can result in better outcomes at a lower cost.
“With broad healthcare reform initiatives focused on growing economic challenges, healthcare systems in every region of the world are striving to continuously improve outcomes, increase access, save cost, and improve the efficiency of healthcare delivery. The acquisition of Cardiocom is one step we are taking toward providing a combination of products and solutions that can help address those challenges,” said Omar Ishrak, chairman and CEO of Medtronic. “With our first integration of this technology focused on heart failure, we will have the unique opportunity to combine our leading diagnostics, therapies and patient management solutions. This combination will strengthen our ability to partner with providers and payers to help them reduce cost and improve quality.”
“We are excited to announce the acquisition of Cardiocom, which provides Medtronic with a technology platform and services that allow physicians to better manage patients with chronic diseases,” said Mike Genau, senior vice president and president of Medtronic’s U.S. Region. “With the integration of Cardiocom, our portfolio of products and services will span the continuum of care for the management of heart failure, which affects an estimated 7.5 million people in the U.S. and is a significant burden to the healthcare system – representing 1.1 million hospital visits per year in the U.S. at a cost of $39 billion each year. We seek to reduce that burden on hospitals, physicians, payers and patients.”
“We look forward to joining Medtronic as part of a combined portfolio of products and solutions that can positively impact outcomes for patients and bring value to our customers,” said Daniel L. Cosentino, vice president and general manager of Cardiocom at Medtronic, and former CEO of Cardiocom. “The synergy between our technologies and Medtronic’s large presence with hospitals, physicians and payers will dramatically increase our distribution channels for the Cardiocom patient management technologies and services. Our approach to care coordination and telehealth services has allowed customers to reduce the overall cost of care, primarily through reduced hospitalizations.”
Source: Medtronic, Inc.